Literature DB >> 8146284

Vitamins as radioprotectors in vivo. I. Protection by vitamin C against internal radionuclides in mouse testes: implications to the mechanism of damage caused by the Auger effect.

V R Narra1, R S Harapanhalli, R W Howell, K S Sastry, D V Rao.   

Abstract

The potential of vitamin C, an antioxidant, to protect the radiosensitive spermatogonial cells in mouse testes against the effects of chronic irradiation by radionuclides incorporated into tissue was investigated. Interestingly, when injected intratesticularly, a small and nontoxic amount of vitamin C (1.5 microgram in 3 microliters saline) protected the spermatogonia against the damage associated with high-LET radiation caused by Auger electrons from similarly administered 5-(125I)-iodo-2'-deoxyuridine (125IdU). A dose modification factor (DMF) of 2.3 was obtained. In contrast, no protection was observed when 210Po, an alpha-particle emitter, was administered similarly. These findings suggest that the mechanism of action of the Auger effect is of an indirect nature, which is in contrast to the direct action generally believed to be responsible for biological damage caused by high-LET radiations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146284

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  9 in total

1.  High Levels of Dietary Supplement Vitamins A, C and E are Absorbed in the Small Intestine and Protect Nutrient Transport Against Chronic Gamma Irradiation.

Authors:  Marjolaine Roche; Prasad V S V Neti; Francis W Kemp; Edouard I Azzam; Ronaldo P Ferraris; Roger W Howell
Journal:  Radiat Res       Date:  2015-10-20       Impact factor: 2.841

2.  Protection by DMSO against cell death caused by intracellularly localized iodine-125, iodine-131 and polonium-210.

Authors:  A Bishayee; D V Rao; L G Bouchet; W E Bolch; R W Howell
Journal:  Radiat Res       Date:  2000-04       Impact factor: 2.841

3.  MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.

Authors:  George Sgouros; John C Roeske; Michael R McDevitt; Stig Palm; Barry J Allen; Darrell R Fisher; A Bertrand Brill; Hong Song; Roger W Howell; Gamal Akabani; Wesley E Bolch; A Bertrand Brill; Darrell R Fisher; Roger W Howell; Ruby F Meredith; George Sgouros; Barry W Wessels; Pat B Zanzonico
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

Review 4.  The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q.

Authors:  R E Beyer
Journal:  J Bioenerg Biomembr       Date:  1994-08       Impact factor: 2.945

5.  Radioprotection against lethal damage caused by chronic irradiation with radionuclides in vitro.

Authors:  R W Howell; S M Goddu; A Bishayee; D V Rao
Journal:  Radiat Res       Date:  1998-10       Impact factor: 2.841

6.  Vitamins A, C, and E May Reduce Intestinal 210Po Levels after Ingestion.

Authors:  Francis W Kemp; Frank Portugal; John M Akudugu; Prasad V S V Neti; Ronaldo P Ferraris; Roger W Howell
Journal:  Health Phys       Date:  2016-07       Impact factor: 1.316

7.  Radiation protection by cysteamine against the lethal effects of intracellularly localized Auger electron, alpha- and beta-particle emitting radionuclides.

Authors:  A Bishayee; D V Rao; R W Howell
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

8.  Study logistics that can impact medical countermeasure efficacy testing in mouse models of radiation injury.

Authors:  Andrea L DiCarlo; Zulmarie Perez Horta; Carmen I Rios; Merriline M Satyamitra; Lanyn P Taliaferro; David R Cassatt
Journal:  Int J Radiat Biol       Date:  2020-09-24       Impact factor: 2.694

Review 9.  Preventive or potential therapeutic value of nutraceuticals against ionizing radiation-induced oxidative stress in exposed subjects and frequent fliers.

Authors:  Maria Teresa Giardi; Eleftherios Touloupakis; Delfina Bertolotto; Gabriele Mascetti
Journal:  Int J Mol Sci       Date:  2013-08-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.